Avalyn Pharma Presents Data Showing Favorable Tolerability and Potential of AP01 to Preserve Forced Vital Capacity in Adults with Pulmonary Fibrosis
Seattle, Sept. 12, 2023 (GLOBE NEWSWIRE) — Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused…
Modern Dental Group Announces 2026 Interim Results
Merdeka Gold Delivers Strong Q2 Production Ramp-Up as Pani Gold Mine Advances Toward Full-year Growth
Nissin Foods Announces 2026 Interim Results
The World’s Leading Minds in Biotechnology Will Meet in Riyadh This September
Overseas Growth Gathers Momentum as CanSinoBIO’s Global Strategy Unlocks New Opportunities